At this point of the discussion, it is worth commenting/postulating that the CTLA-4 c.-1577G>A SNV can alter the survival of CM patients treated only with surgical tumor resection and conventional chemotherapy, as seen in our cases, possibly due to deregulation of the immune system. The gene discussed is CTLA4; the disease is neoplasm.